XHQLX: Tekla Life Sciences Investors - MutualFunds.com
Continue to site >
Trending ETFs

Name

Price

Aum/Mkt Cap

YIELD & DIV

Exp Ratio

Watchlist

$22.31

-

-

1.66%

Vitals

YTD Return

3.1%

1 yr return

20.0%

3 Yr Avg Return

10.1%

5 Yr Avg Return

12.3%

Net Assets

$545 M

Holdings in Top 10

44.0%

52 WEEK LOW AND HIGH

$22.26
$19.47
$24.19

Expenses

OPERATING FEES

Expense Ratio 1.66%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover 51.27%

Redemption Fee N/A


Min Investment

Standard (Taxable)

N/A

IRA

N/A


Fund Classification

Fund Type

Closed-end mutual fund

Investment Style

Health


Name

Price

Aum/Mkt Cap

YIELD & DIV

Exp Ratio

Watchlist

$22.31

-

-

1.66%

XHQLX - Profile

Distributions

  • YTD Total Return 3.1%
  • 3 Yr Annualized Total Return 10.1%
  • 5 Yr Annualized Total Return 12.3%
  • Capital Gain Distribution Frequency N/A
  • Net Income Ratio -0.47%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Quarterly

Fund Details

  • Legal Name
    Tekla Life Sciences Investors
  • Fund Family Name
    Hambrecht & Quist
  • Inception Date
    May 08, 1992
  • Shares Outstanding
    24466208
  • Share Class
    N/A
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Daniel Omstead

Fund Description

N/A


XHQLX - Performance

Return Ranking - Trailing

Period XHQLX Return Category Return Low Category Return High Rank in Category (%)
YTD 3.1% -80.1% 37.9% 81.69%
1 Yr 20.0% -28.4% 92.6% 77.78%
3 Yr 10.1%* -0.3% 38.2% 81.76%
5 Yr 12.3%* 2.2% 38.6% 84.51%
10 Yr 16.7%* 9.4% 21.6% 55.28%

* Annualized

Return Ranking - Calendar

Period XHQLX Return Category Return Low Category Return High Rank in Category (%)
2020 10.9% -13.6% 178.2% 63.95%
2019 17.0% 3.8% 63.8% 77.24%
2018 -16.4% -49.7% 21.5% 88.32%
2017 10.0% -59.8% 54.4% 80.00%
2016 -25.1% -36.6% 11.6% 93.75%

Total Return Ranking - Trailing

Period XHQLX Return Category Return Low Category Return High Rank in Category (%)
YTD 3.1% -79.8% 42.1% 82.63%
1 Yr 20.0% -30.4% 92.6% 67.87%
3 Yr 10.1%* -15.9% 38.2% 79.89%
5 Yr 12.3%* -7.4% 38.6% 70.52%
10 Yr 16.7%* 9.4% 21.6% 51.13%

* Annualized

Total Return Ranking - Calendar

Period XHQLX Return Category Return Low Category Return High Rank in Category (%)
2020 10.9% -13.6% 178.2% 63.95%
2019 17.0% 3.8% 63.8% 77.24%
2018 -16.4% -25.3% 22.2% 89.78%
2017 10.0% -10.8% 54.4% 89.63%
2016 -25.1% -36.6% 11.6% 96.88%

NAV & Total Return History


XHQLX - Holdings

Concentration Analysis

XHQLX Category Low Category High XHQLX % Rank
Net Assets 545 M 2.72 M 53.2 B 54.55%
Number of Holdings 145 11 478 15.25%
Net Assets in Top 10 221 M 2.18 K 21.1 B 40.68%
Weighting of Top 10 43.98% 10.1% 94.7% 31.36%

Top 10 Holdings

  1. Gilead Sciences Inc 7.09%
  2. Amgen Inc 5.70%
  3. Illumina Inc 5.49%
  4. Vertex Pharmaceuticals Inc 5.02%
  5. Seagen Inc Ordinary Shares 4.64%
  6. Moderna Inc 4.49%
  7. Regeneron Pharmaceuticals Inc 4.22%
  8. Alexion Pharmaceuticals Inc 4.15%
  9. Biogen Inc 3.75%
  10. Horizon Therapeutics PLC 3.71%

Asset Allocation

Weighting Return Low Return High XHQLX % Rank
Stocks
94.65% 83.68% 104.21% 94.07%
Preferred Stocks
5.23% 0.00% 5.83% 2.12%
Cash
0.21% -0.65% 9.16% 47.03%
Convertible Bonds
0.00% 0.00% 0.06% 40.25%
Bonds
0.00% 0.00% 17.12% 42.80%
Other
-0.10% -26.05% 9.11% 95.34%

Stock Sector Breakdown

Weighting Return Low Return High XHQLX % Rank
Healthcare
99.83% 61.99% 100.00% 45.76%
Financial Services
0.17% 0.00% 1.78% 22.88%
Utilities
0.00% 0.00% 0.98% 40.25%
Technology
0.00% 0.00% 19.13% 45.34%
Real Estate
0.00% 0.00% 6.19% 43.22%
Industrials
0.00% 0.00% 7.02% 44.49%
Energy
0.00% 0.00% 0.71% 40.25%
Communication Services
0.00% 0.00% 7.81% 42.37%
Consumer Defense
0.00% 0.00% 28.21% 45.34%
Consumer Cyclical
0.00% 0.00% 17.63% 43.64%
Basic Materials
0.00% 0.00% 8.23% 55.93%

Stock Geographic Breakdown

Weighting Return Low Return High XHQLX % Rank
US
88.49% 57.23% 100.70% 47.46%
Non US
6.16% 0.00% 42.77% 76.69%

XHQLX - Expenses

Operational Fees

XHQLX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 1.66% 0.08% 2.91% 13.85%
Management Fee 1.00% 0.00% 1.25% 88.64%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.03% 0.25% N/A

Sales Fees

XHQLX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 0.00% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

XHQLX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

XHQLX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 51.27% 0.00% 256.00% 61.68%

XHQLX - Distributions

Dividend Yield Analysis

XHQLX Category Low Category High XHQLX % Rank
Dividend Yield 0.00% 0.00% 2.44% 48.09%

Dividend Distribution Analysis

XHQLX Category Low Category High Category Mod
Dividend Distribution Frequency Quarterly Annually Monthly Semi-Annually

Net Income Ratio Analysis

XHQLX Category Low Category High XHQLX % Rank
Net Income Ratio -0.47% -2.54% 1.92% 79.19%

Capital Gain Distribution Analysis

XHQLX Category Low Category High Capital Mode
Capital Gain Distribution Frequency

Dividend Payout History

View More +

XHQLX - Fund Manager Analysis

Managers

Daniel Omstead


Start Date

Tenure

Tenure Rank

Sep 30, 2001

19.93

19.9%

Omstead is president and chief executive officer of Tekla Capital Management, formerly known as Hambrecht & Quist Capital Management, Inc. Before joining the adviser, Omstead was president and CEO of Reprogenesis, Inc., a private development stage biotech company developing therapies in the field of regenerative medicine. Before joining Reprogenesis, he was senior vice president, research and development at Cytotherapeutics, Inc., a public biotech company that developed CNS therapies.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.03 23.98 6.66 1.38